Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999.
about
Moraxella catarrhalis bacterium without endotoxin, a potential vaccine candidateActivity of telithromycin and comparators against bacterial pathogens isolated from 1,336 patients with clinically diagnosed acute sinusitisMolecular Architecture of DesI: A Key Enzyme in the Biosynthesis of Desosamine † , ‡Outpatient antibiotic use and prevalence of antibiotic-resistant pneumococci in France and Germany: a sociocultural perspectiveUse of germicides in the home and the healthcare setting: is there a relationship between germicide use and antibiotic resistance?Maintaining fluoroquinolone class efficacy: review of influencing factors.Single-dose (30 mg/kg) azithromycin compared with 10-day amoxicillin/clavulanate for the treatment of uncomplicated acute otitis media: a double-blind, placebo-controlled, randomized clinical trial.Identification of a 3-deoxy-D-manno-octulosonic acid biosynthetic operon in Moraxella catarrhalis and analysis of a KdsA-deficient isogenic mutantKetolide resistance in Streptococcus pyogenes correlates with the degree of rRNA dimethylation by Erm.Increase in pneumococcus macrolide resistance, United States.Therapeutic efficacy of meropenem for treatment of experimental penicillin-resistant pneumococcal meningitisPreliminary pharmaceutical development of antimalarial-antibiotic cotherapy as a pre-referral paediatric treatment of fever in malaria endemic areas.Risk factors associated with colonization by pneumococci with reduced susceptibility to fluoroquinolones in adult outpatients.A pilot study of single-dose azithromycin versus three-day azithromycin or single-dose ceftriaxone for uncomplicated acute otitis media in childrenRoles of 3-deoxy-D-manno-2-octulosonic acid transferase from Moraxella catarrhalis in lipooligosaccharide biosynthesis and virulence.Nasopharyngeal carriage of antimicrobial-resistant Streptococcus pneumoniae among young children attending 79 kindergartens and day care centers in Hong Kong.Antimicrobial resistance in Haemophilus influenzae isolated during population-based surveillance for meningitis in Salvador, Brazil.Specific immune responses and enhancement of murine pulmonary clearance of Moraxella catarrhalis by intranasal immunization with a detoxified lipooligosaccharide conjugate vaccine.Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications.From microbial gene essentiality to novel antimicrobial drug targetsAntimicrobial surveillance of Haemophilus influenzae in the United States during 2000-2001 leads to detection of clonal dissemination of a beta-lactamase-negative and ampicillin-resistant strainPneumococcal resistance to macrolides, lincosamides, ketolides, and streptogramin B agents: molecular mechanisms and resistance phenotypes.Delafloxacin: design, development and potential place in therapyDelafloxacin for the treatment of respiratory and skin infections.Using interrupted time series analysis to assess associations of fluoroquinolone formulary changes with susceptibility of gram-negative pathogens and isolation rates of methicillin-resistant Staphylococcus aureusWorldwide antimicrobial susceptibility patterns and pharmacodynamic comparisons of gatifloxacin and levofloxacin against Streptococcus pneumoniae: report from the Antimicrobial Resistance Rate Epidemiology Study TeamRhinosinusitis diagnosis and management for the clinician: a synopsis of recent consensus guidelines.Antimicrobial resistance in respiratory tract Streptococcus pneumoniae isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002Antimicrobial resistance in Haemophilus influenzae and Moraxella catarrhalis respiratory tract isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002Quinupristin-dalfopristin resistance in Streptococcus pneumoniae: novel L22 ribosomal protein mutation in two clinical isolates from the SENTRY antimicrobial surveillance program.Antagonism of miR-328 increases the antimicrobial function of macrophages and neutrophils and rapid clearance of non-typeable Haemophilus influenzae (NTHi) from infected lungAntibiotic treatment for bacterial meningitis in children in developing countries.Measurement of cefaclor and amoxicillin-clavulanic acid levels in middle-ear fluid in patients with acute otitis media.Genotypes and related factors reflecting macrolide resistance in pneumococcal pneumonia infections in Japan.Antimicrobial Susceptibility/Resistance of Streptococcus Pneumoniae.Resistance to antimicrobial agents: an update.Treating serious infections: focus on cefepime.Emergence and spread of Streptococcus pneumoniae with erm(B) and mef(A) resistanceIn vitro antibacterial potency and spectrum of ABT-492, a new fluoroquinolone.Mechanisms of resistance to quinolones.
P2860
Q24536085-C0B0D3C2-498E-4334-96D0-682213C05CC6Q24798440-171731FA-8982-4FDD-87C6-B36029144244Q27646687-B9988293-D13D-4FB9-ACE9-B754CBF10083Q28194501-80B17CA8-FFD6-402D-8A6B-6F147CE7A3A2Q28265803-EE6C61E3-4E6C-4EDB-A0BD-5875984D063BQ30310427-D9D5B658-B54F-42F0-A94E-B6D10A2197B1Q30436538-1C3B1DD2-543D-44F3-A7D7-54B0FE64113FQ31015760-302CA9AE-FF83-4F83-A216-DC725A3C21C1Q33224241-9B5456AD-9661-4303-874C-7A8DEA79059DQ33628610-37C58224-39EF-4D7B-BD44-9B1C4F5B6E35Q33654490-4348E14E-4793-4262-BBB5-84EBC7C9F686Q33710687-2F90ACF4-049D-4080-9336-599BA3B30DF7Q33752905-8BF127DF-BB92-4F67-BC18-A20611FAB2ECQ33772380-2B8A2AD5-4C62-4262-86DA-834E1CBF8DE1Q33883531-F0E22624-6CB5-4F02-8A06-5056B8F6A191Q33983099-2610605E-BE2B-4D20-8B8A-25681F9F51D3Q34142475-33B34C68-9E2B-4F8A-9579-A690B6890B67Q34183386-3628C68F-BDC5-4B9A-813D-D41751CFD6DCQ34498620-84F00F35-329C-43A1-A7AB-E3B4349DCF75Q34517482-D8047F8F-EEAE-4A7C-9B06-3FE7E577C446Q34521482-CA26270B-21CE-49DD-AF30-9D9FD977201BQ34547639-E864A8D2-2941-4C06-88C3-F6F97448C7EDQ34554381-6FF09BAA-A3B7-4212-A645-41186DC8283DQ34667588-72EC435C-DAEC-4F44-AF40-CA0A27DFC157Q34680578-2DD84B11-7C39-4313-B782-433FA9562138Q34725279-98B038A2-E102-4501-9C5E-4C773F772779Q34887935-6A4F3323-7BE7-4465-BC45-4BCAE6D2D6E8Q35013962-670D81AC-5CFC-4EBA-9556-285572EB1C2CQ35014040-3B114F70-FB55-46CD-AAE3-FE72F0569AA9Q35165803-A11D2643-7BCB-400C-B801-C0B8B30BCF3FQ35610043-BAFC894B-5A71-4EB0-ACFD-C9A6977A4A65Q35635850-491878D6-49F5-4AA1-A2B5-DC6A1D4974A1Q35685371-30833919-3D96-42E6-8DBA-D6292AC05541Q35784460-5758EDBE-3F07-4164-88F2-5124452CB87CQ35842871-26FE4A01-CAD9-4370-B8C5-D96B5FDCB049Q35976850-689E14D9-0D39-4FE6-AD1D-E19C92DA6C4BQ35976856-E1DF8864-7990-47BE-88F2-0D050DF8B2BEQ36009392-AC67BFE1-D015-408C-9130-6C7A58770595Q36048301-D69FF9FE-6B4B-4107-8130-B05936E0DE85Q36155441-1AEB971E-73D5-45F8-AC71-24CD89AF1B54
P2860
Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Worldwide prevalence of antimi ...... rveillance Program, 1997-1999.
@en
Worldwide prevalence of antimi ...... rveillance Program, 1997-1999.
@nl
type
label
Worldwide prevalence of antimi ...... rveillance Program, 1997-1999.
@en
Worldwide prevalence of antimi ...... rveillance Program, 1997-1999.
@nl
prefLabel
Worldwide prevalence of antimi ...... rveillance Program, 1997-1999.
@en
Worldwide prevalence of antimi ...... rveillance Program, 1997-1999.
@nl
P2093
P2860
P356
P1476
Worldwide prevalence of antimi ...... rveillance Program, 1997-1999.
@en
P2093
Roussel-Delvallez M
P2860
P304
P356
10.1086/320181
P407
P478
32 Suppl 2
P577
2001-05-01T00:00:00Z